Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Detection of Lower Adherence to Long-Term e-Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Behavioral impairments in Africanized Apis mellifera exposed to lethal and sublethal doses of acetamiprid, fipronil, and thiamethoxam.

Ecotoxicology (London, England)·2025
Same author

Report of Oestrus sp. larvae in the nasal cavity of sheep from the Azores archipelago.

Veterinary parasitology, regional studies and reports·2025
Same author

Touch Empowerment: Self-Sustaining e-Tattoo Thermoelectric System for Temperature Mapping.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024
Same author

Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.

Journal of investigational allergology & clinical immunology·2024
Same author

Understanding beliefs about inhaled medication in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.

European annals of allergy and clinical immunology·2024

Related Experiment Video

Updated: May 31, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.2K

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

B Sousa-Pinto1,2, M Savouré3, R J Vieira1,2

  • 1MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal.

Journal of Investigational Allergology & Clinical Immunology
|January 23, 2025
PubMed
Summary

Persistent allergic rhinitis is more strongly linked to asthma than rhinitis severity. Comorbid asthma often leads to poorer rhinitis control across ARIA classifications.

Keywords:
Allergic rhinitisAsthmamHealth

More Related Videos

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.6K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

389

Related Experiment Videos

Last Updated: May 31, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.2K
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.6K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

389

Area of Science:

  • Allergy and immunology
  • Respiratory medicine
  • Real-world evidence studies

Background:

  • The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines classify rhinitis by duration (intermittent/persistent) and severity (mild/moderate-severe).
  • Understanding phenotypic differences within ARIA classes is crucial for managing comorbid asthma.

Purpose of the Study:

  • To assess ARIA classification frequencies in a real-world setting.
  • To compare phenotypic differences across ARIA classes.
  • To investigate the association between rhinitis and comorbid asthma.

Main Methods:

  • Cross-sectional study using MASK-air® app data from 2273 users with at least 3 months of data.
  • Assessed ARIA class frequency, rhinitis symptoms (VAS), medication use, and asthma comorbidity.
  • Compared rhinitis control in patients with and without asthma.

Main Results:

  • 88.1% had moderate-severe and 50.3% had persistent rhinitis.
  • Probable asthma prevalence was 35.7% in intermittent and 48.5% in persistent rhinitis.
  • Patients with comorbid asthma showed higher symptom scores and more frequent medication use.

Conclusions:

  • Rhinitis persistence, not severity, is more closely associated with asthma.
  • Comorbid asthma may be linked to poorer rhinitis control across ARIA classes.